Yeah, a commercial agreement for Anteobind should catch the market by surprise with all the expectations being on the battery developments. I feel the market is asleep to the potential of Anteobind post-Eugeni debacle, and rightfully so. It still remains a huge market opportunity and was a very embarrassing episode for the company & LT shareholders given the tech was 100% externally validated (despite what sea monsters would have you believe).
With the right agreement (talk of JV's/acquisitions etc.), shareholders may finally feel some vindication.
ADO Price at posting:
4.8¢ Sentiment: Buy Disclosure: Held
